Biologics License Application

Dallas, Texas, USA, September 9, 2026 Nanoscope Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has...

Reykjavik, Iceland – August 31, 2026 Alvotech announced that the U.S. FDA has accepted for review its Biologics License...

Berlin, Germany, August 30, 2026 Bayer announced detailed results from the Phase 3 REVEAL study evaluating investigational PET radiotracer...

Durham, North Carolina, August 29, 2026 AskBio Inc. presented baseline characteristics from its Phase 2 GenePHIT clinical trial evaluating...

Cambridge, Massachusetts, August 27, 2026 Moderna, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved supplemental...

CAMBRIDGE, Mass., August 7, 2026 Scholar Rock announced that the U.S. Food and Drug Administration (FDA) review of its...

BRISBANE, Calif., August 6, 2026 Annexon, Inc. announced encouraging early clinical results from the ongoing FORWARD open-label study, with...

CAMBRIDGE, Mass., August 6, 2026 Vedanta Biosciences announced it has secured $60 million in funding to accelerate development of...

Cambridge, Massachusetts, August 4, 2026 Marengo Therapeutics has announced a major advancement in its strategic TriSTAR™ collaboration with Ipsen,...

New York, New York, August 4, 2026 Nuvation Bio has announced that it will present new subgroup analyses from...